Turning paper tests into
clinical intelligence
IntelliScape LLC came with a problem and no product. We left them with a cross-platform cognitive screening tool now in FDA clinical trials.
The Starting Point
A real clinical problem. No product yet.
IntelliScape came to Digitea after connecting with a doctor who had identified a clear gap in cognitive health screening. Paper-based assessments were inconsistent, slow to score, and nearly impossible for elderly patients to complete without constant assistance. They knew it needed to change. They did not know how.
There was no brief. No wireframe. No stack. Just a problem worth solving and a team willing to build the right thing.
"They came with a problem. We shaped the product, built the team, and shipped something the market had not seen before."
End to End Ownership
Everything. From first conversation to live product.
Digitea took full ownership across every layer of the product. Not a handoff model. Not advisory. We built it.
What Makes It Different
Built for the hardest users in the room.
Cognitive screening tools fail elderly patients all the time. Brain Compass was designed so they never would.
The Product
Interface screenshots
The Process
How we got from idea to clinical trials.
We came to Digitea with an idea and nothing else. Vaarun shaped the whole product with us, pushed back where it mattered, and the team built everything from the ground up. Design, branding, development, all of it. Brain Compass is now in successful beta and going through FDA clinical trials. We could not have asked for a better partner.
Let's build something that lasts.
We work best when the problem is hard and the stakes are real.
Talk to us →